Ryan Ho-Yan Wong
Chief Financial Officer · Sarepta Therapeutics, Inc.
Individual
- 2025
- Sep 9, 2026
- 7
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ryan Ho-Yan Wong files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Ian Michael Estepan - $294K in SRPT purchases and sales in the last 12 months
- Stephen Mayo - $123K in SRPT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ryan Ho-Yan Wong?
Ryan Ho-Yan Wong is a corporate insider, tracked as Chief Financial Officer of Sarepta Therapeutics, Inc. (SRPT). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Ryan Ho-Yan Wong submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
